Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.46 SEK | -.--% | +2.83% | +6.77% |
May. 08 | Vimab Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Vimab Group AB (OM:VIMAB) agreed to acquire Tranfoten Aktiebolag. | CI |
Sales 2022 | 227M 21.6M | Sales 2023 | 342M 32.53M | Capitalization | 191M 18.17M |
---|---|---|---|---|---|
Net income 2022 | -34M -3.23M | Net income 2023 | -4M -380K | EV / Sales 2022 | 0.86 x |
Net Debt 2022 | 22.11M 2.1M | Net Debt 2023 | 103M 9.76M | EV / Sales 2023 | 0.86 x |
P/E ratio 2022 |
-2.58
x | P/E ratio 2023 |
-43.6
x | Employees | 170 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 15.2% |
1 week | +2.83% | ||
1 month | -9.90% | ||
3 months | +8.74% | ||
6 months | -1.97% | ||
Current year | +6.77% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Fredell
CEO | Chief Executive Officer | 59 | 19-12-31 |
Anna Farmer
DFI | Director of Finance/CFO | - | 20-12-31 |
Philip Appelsved
SAM | Sales & Marketing | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 77 | 21-12-31 | |
Peter Fredell
CEO | Chief Executive Officer | 59 | 19-12-31 |
Director of Finance/CFO | 59 | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 9.46 | -.--% | 101 |
24-05-30 | 9.46 | +4.19% | 3,618 |
24-05-29 | 9.08 | -0.22% | 8,656 |
24-05-28 | 9.1 | -2.57% | 15,864 |
24-05-27 | 9.34 | +1.52% | 1,242 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 05:06 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+6.77% | 20.06M | |
+7.86% | 7.53B | |
-35.29% | 3.09B | |
+6.46% | 2.67B | |
-6.44% | 1.47B | |
-15.81% | 1.01B | |
+10.22% | 760M | |
-14.47% | 656M | |
-2.02% | 616M | |
-9.06% | 603M |
- Stock Market
- Equities
- VIMAB Stock